327 related articles for article (PubMed ID: 25956235)
1. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
[TBL] [Abstract][Full Text] [Related]
2. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
3. Ramelteon: a novel approach in the treatment of insomnia.
Reynoldson JN; Elliott E; Nelson LA
Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
[TBL] [Abstract][Full Text] [Related]
4. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
[TBL] [Abstract][Full Text] [Related]
5. Ramelteon: profile of a new sleep-promoting medication.
Owen RT
Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
Devi V; Shankar PK
J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808
[TBL] [Abstract][Full Text] [Related]
7. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
8. [A novel therapeutic drug: ramelteon].
Miyamoto M
Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
[TBL] [Abstract][Full Text] [Related]
9. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
10. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
Mishima K
Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.
Kohsaka M; Kanemura T; Taniguchi M; Kuwahara H; Mikami A; Kamikawa K; Uno H; Ogawa A; Murasaki M; Sugita Y
Expert Rev Neurother; 2011 Oct; 11(10):1389-97. PubMed ID: 21955196
[TBL] [Abstract][Full Text] [Related]
12. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
Kuriyama A; Honda M; Hayashino Y
Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
[TBL] [Abstract][Full Text] [Related]
13. Ramelteon.
McGechan A; Wellington K
CNS Drugs; 2005; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
[TBL] [Abstract][Full Text] [Related]
14. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
[TBL] [Abstract][Full Text] [Related]
15. Ramelteon: new drug. Insomnia: no role for risky placebos.
Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
[TBL] [Abstract][Full Text] [Related]
17. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.
Karim A; Tolbert D; Cao C
J Clin Pharmacol; 2006 Feb; 46(2):140-8. PubMed ID: 16432265
[TBL] [Abstract][Full Text] [Related]
18. Ramelteon-induced nightmares: A case report.
Shah C; Kablinger A
Asian J Psychiatr; 2015 Dec; 18():111-2. PubMed ID: 26427581
[TBL] [Abstract][Full Text] [Related]
19. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S; Watissée M; Roth T
Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
[TBL] [Abstract][Full Text] [Related]
20. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
